Senti Biosciences's total assets for Q4 2024 were $97.84M, an increase of 69.51% from the previous quarter. SNTI total liabilities were $72.19M for the fiscal quarter, a 73.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.